Why the prostate arm of the PLCO trial-failed and what it has taught us

摘要

Given a recent update from the PLCO trial reporting that over 90% of men in the 'usual care' arm underwent some degree of PSA testing, the PLCO can no longer accurately be called a trial of screening versus no screening-nor can it be included as such in meta-analyses or guideline statements.